Internal Medicine, Endocrinology, Diabetes, & Metabolism · Beaumont, TX
NPI
1447258850
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3440 Fannin St
Beaumont, TX, 77701
Phone (409) 833-6900
Groups this clinician bills Medicare through
Medicare paid, 2024
$330K
16,366 services
Medicare patients, 2024
985
Average age 73
Drug cost, 2024
$6.0M
11,759 prescriptions
Company payments, 2025
$1,207
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kandaswamy Jayaraj was code 99214 (office e&m - established), 1,468 times for 727 patients. In total Kandaswamy Jayaraj billed 16,366 services in 51 codes, and Medicare paid $330K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-08-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,468 | 727 | $82.84 | $122K |
| 36415 Venipuncture Blood Collection | Office | 1,357 | 753 | $7.68 | $10K |
| 83036 Blood Count | Office | 895 | 411 | $9.40 | $8,414 |
| 84443 Clinical Chemistry | Office | 843 | 612 | $16.30 | $14K |
| 80061 Clinical Chemistry | Office | 807 | 385 | $12.98 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 789 | 434 | $12.20 | $9,625 |
| 84439 Clinical Chemistry | Office | 720 | 514 | $8.76 | $6,306 |
| 82565 Clinical Chemistry | Office | 679 | 347 | $4.95 | $3,363 |
| 84520 Clinical Chemistry | Office | 679 | 347 | $3.82 | $2,592 |
| 84460 Clinical Chemistry | Office | 678 | 347 | $5.13 | $3,476 |
| 84295 Clinical Chemistry | Office | 677 | 346 | $4.65 | $3,145 |
| 82040 Clinical Chemistry | Office | 677 | 347 | $4.80 | $3,248 |
| 82310 Clinical Chemistry | Office | 677 | 347 | $5.00 | $3,388 |
| 82374 Clinical Chemistry | Office | 677 | 346 | $4.72 | $3,192 |
| 84450 Clinical Chemistry | Office | 677 | 347 | $5.02 | $3,402 |
By year: 2022 $316K for 13,769 services; 2023 $345K for 16,221 services; 2024 $330K for 16,366 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,357 | 753 | $7.68 | $10K |
| 83036 Blood Count | 895 | 411 | $9.40 | $8,414 |
| 84443 Clinical Chemistry | 843 | 612 | $16.30 | $14K |
| 80061 Clinical Chemistry | 807 | 385 | $12.98 | $10K |
| 84439 Clinical Chemistry | 720 | 514 | $8.76 | $6,306 |
| 82565 Clinical Chemistry | 679 | 347 | $4.95 | $3,363 |
| 84520 Clinical Chemistry | 679 | 347 | $3.82 | $2,592 |
| 84460 Clinical Chemistry | 678 | 347 | $5.13 | $3,476 |
| 84295 Clinical Chemistry | 677 | 346 | $4.65 | $3,145 |
| 82040 Clinical Chemistry | 677 | 347 | $4.80 | $3,248 |
Medicare prescription drug claims, 2024
In 2024, the drug Kandaswamy Jayaraj prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,433 prescriptions and refills. In total Kandaswamy Jayaraj wrote 11,759 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,433 | 3,984 | 444 | $16K |
| Ozempic Semaglutide | 1,321 | 2,238 | 301 | $2.1M |
| Rosuvastatin Calcium Generic | 778 | 2,211 | 274 | $11K |
| Glimepiride Generic | 551 | 1,495 | 166 | $5,097 |
| Mounjaro Tirzepatide | 473 | 713 | 105 | $739K |
| Metformin Hcl Er Metformin Hcl | 410 | 1,160 | 152 | $3,449 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 371 | 735 | 94 | $401K |
| Tresiba Flextouch U-200 Insulin Degludec | 366 | 794 | 112 | $403K |
| Jardiance Empagliflozin | 348 | 602 | 93 | $337K |
| Farxiga Dapagliflozin Propanediol | 335 | 627 | 101 | $332K |
| Metformin Hcl Generic | 284 | 733 | 89 | $2,129 |
| Atorvastatin Calcium Generic | 271 | 776 | 94 | $2,186 |
| Synthroid Levothyroxine Sodium | 223 | 623 | 67 | $9,397 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 222 | 414 | 53 | $225K |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 207 | 387 | 70 | $73K |
Brand drugs: 6,088 claims; generic drugs: 5,099 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kandaswamy Jayaraj $1,207 ($1,207 in general payments such as food, travel and fees) from 14 companies. The largest payer was Novo Nordisk Inc with $221.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 13 | $221 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $211 |
| Lilly USA, LLC LLY | 11 | $185 |
| Dexcom, Inc. DXCM | 7 | $142 |
| Radius Health, Inc. | 2 | $71.8 |
| Beta Bionics, Inc. BBNX | 2 | $54.86 |
| Sequel Med Tech, LLC | 2 | $53.62 |
| Insulet Corporation PODD | 3 | $52.66 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $48.34 |
| Amgen Inc. AMGN | 3 | $41.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.